Consistent with this, MYLK knock-in mice carrying kinase-inactivating mutations develop ascending aortic aneurysms before 6 months of age, further confirming that defective smooth muscle cell contraction is sufficient to trigger aneurysmal dilation (Wang et al., 2010). The gene discussed is MYLK; the disease is Ascending tubular aorta aneurysm.